Household products maker Clorox Q1 revenue beats analyst expectations

The Clorox

03/11/2025 21:21

Overview

Clorox fiscal Q1 revenue decreased 19% but beat analyst expectations

Adjusted EPS for fiscal Q1 beats consensus despite a 54% year-over-year decrease

Company's ERP transition led to lower shipments and sales decline

Outlook

Clorox maintains FY 2026 net sales outlook to decline 6% to 10%

Clorox expects FY 2026 adjusted EPS to be $5.95 to $6.30

Company focuses on innovation and demand-creation for H2 growth

Result Drivers

ERP TRANSITION - Lower shipments and sales decline attributed to ERP transition as retailers drew down inventories built up in anticipation of the transition

HIGHER COSTS - Gross margin decreased due to higher manufacturing and logistics costs, partially offset by cost savings

PRODUCT INNOVATION - New products introduced to align with emerging consumer trends, aiming to deliver superior value

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
$1.43 bln
$1.39 bln (12 Analysts)
Q1 ADJUSTED EPS
Beat
$0.85
$0.78 (13 Analysts)
Q1 EPS
$0.65
Q1 GROSS MARGIN
41.7%


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 14 "hold" and 4 "sell" or "strong sell"

The average consensus recommendation for the household products peer group is "buy."

Wall Street's median 12-month price target for Clorox Co is $128.00, about 12.1% above its October 31 closing price of $112.46

The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 19 three months ago

Press Release: ID:nPn1QwcvQa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)